Elite takeover heats up
...bid rises to $1.99 per share
RESOURCE Assets Limited (RAL), a company controlled by Donovan and Kathryn Lewis, has launched a $353.03-million mandatory takeover bid for the remaining ordinary shares of Elite Diagnostic Limited based on guidance from the Financial Services Commission (FSC).
The offer circular was published on Thursday and revealed that the offer price had been adjusted to $1.99 per ordinary share, a 24 per cent premium above the previously proposed $1.60 price. RAL currently controls 49.80 per cent of Elite’s ordinary shares and will be seeking to acquire 177.40 million shares currently held by other shareholders.
Trading activity in Elite Diagnostic, a stock that had previously seen relatively thin trading on the Jamaica Stock Exchange (JSE), began picking up in July when Three Bears Limited, an entity controlled by businessman Donovan Lewis, acquired Sagicor Sigma Optima unit trust’s 8.90 per cent stake for $44.01 million on July 6.
RAL subsequently spent $370.51 million acquiring 61.90 per cent of Elite’s ordinary shares between August 28 and October 1, purchasing the holdings of some of the company’s largest shareholders. Additional trades by RAL and Three Bears brought Donovan Lewis’ effective control of Elite to 73.49 per cent, representing 259,729,869 ordinary shares acquired at a combined cost of $427.80 million.
The October 1 acquisition, however, pushed RAL’s ownership beyond 50 per cent of Elite’s voting rights, triggering the takeover bid.
“The Offeror was mandated by the FSC to make this offer as a mandatory offer to minority shareholders based on determinations by the FSC that such a mandatory offer was required to be made in circumstances where the Offeror had acquired shares in the capital of Elite at a time and in a manner considered relevant by the FSC,” the circular said.
Rather than proceeding with the mandatory offer, RAL sold 23.69 per cent of Elite, or 83,729,869 ordinary shares, on October 6, including a 3.69 per cent stake acquired directly by Ideal Portfolio Services Company Limited, a company also connected to Lewis.
Thereafter, RAL’s shareholding in Elite was lowered to 38.20 per cent and below the 50 per cent threshold. It then purchased Three Bears entire 11.60 per cent ownership in Elite on October 9, moving its stake in Elite back up to 49.80 per cent.
Nonetheless, Lewis’s companies retain a combined 53.49 per cent stake in Elite Diagnostic.
RAL’s initially proposed $1.60 offer price was slightly below the $1.61 book value of Elite as of June 30. The current $1.99 price per share is just shy of the $2.00 IPO price from when it went public in February 2018.
Meanwhile, Elite, a company that provides services including MRI, CT scans and X-rays, had initially planned to publish its directors’ circular within seven days of receiving the takeover bid. It announced on Monday that the document, which will advise shareholders on whether to accept or reject the offer, will instead be released on November 17.
The junior market-listed company said it needed more time to obtain a specialist valuation of some of its equipment and for its independent financial adviser to complete an opinion on whether the offer is fair and reasonable. Additionally, the independent financial advisor’s opinion required that valuation report to finalise their report.
“The board considers that shareholders should have the benefit of both the valuation and the independent opinion before deciding whether to accept the offer,” the Elite board stated.
Since RAL and Ideal Portfolio Services acquired majority shares in Elite, there have been changes to the company’s board composition. Director Simone Bowie Jones resigned as a director on October 9, ending three years of service on the board. Jones, an attorney-at-law, was the chair of Elite’s corporate governance committee and a member of its audit committee.
Meanwhile, Dr David Alexander Walcott, Victoria Hobbs-Meeks and Kathryn Lewis-Green joined Elite’s board on November 1. Their appointments expands Elite’s board to nine directors.
Dr Walcott is the founder of Novamed while Hobbs-Meeks is known as the managing director of The Alchemist Pharmacy. Lewis-Green is an attorney-at-law who sits on several boards such as Sagicor Life Jamaica Limited, Salada Foods Jamaica Limited and Paramount Trading (Jamaica) Limited.
“If this offer succeeds and the offeror acquires control of Elite then its present intention is that certain changes to Elite’s management and board of directors may occur as a result of the transaction, but no decisions have been made in this regard as at the date of issue of this offer circular,” the circular added.
According to the circular, the company intends to apply Section 209 (1) of the Jamaican Companies Act if the relevant requirements are meet. It means Elite could be delisted if sufficient shares are tendered in the offer. JSE Junior Market rules require at least 50 shareholders own at least 20 per cent of a company’s voting shares for that firm to remain listed.
Elite’s share price rose five per cent on Friday to close at $1.79 as investors reacted to the revised takeover price. The stock traded between $1.76 and $1.99 during the session.
The offer opens on November 16 and is scheduled to close on December 21, overlapping Elite’s annual general meeting, scheduled for 10:00 a.m. on December 10 at the Terra Nova All-Suite Hotel.

